Top three insurers reaped $7.3 billion through their drug middlemen's markups, FTC says
Regulators published their most detailed findings yet on how some of the nation’s largest companies profited from "excess" prescription price hikes of 1,000% or more.
PBMs made billions marking up speciality drugs by more than 1,000 percent: FTC
The Federal Trade Commission (FTC) on Tuesday released its second interim report on pharmacy benefit managers (PBM), saying the major industry middlemen generate billions in revenue through
Big 3 PBMs reaped $7.3B from generic specialty drug markups: FTC
The Federal Trade Commission voted unanimously to release additional findings from its yearslong probe into CVS Caremark, OptumRx and Express Scripts.
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs between 2017 and 2022,
FTC says ‘Big 3 PBMs’ marked up generic drugs by thousands of percent
The Federal Trade Commission published a second interim staff report on the prescription drug middleman industry, which it says focuses on
PBMs Generated Billions in Drug Markups, FTC Says
Major pharmacy-benefit managers generated $7.3 billion in markups on specialty drugs from pharmacies they are affiliated with, the FTC said in a new report.
FTC finds PBMs excessively marked up prices on specialty drugs
A new report issued by the Federal Trade Commission has found that prescription benefit manager units owned by CVS Health (NYSE:CVS), Cigna (CI) and UnitedHealth Group (UNH) significantly marked up prices for many specialty generic drugs over a six-year period.
CVS Health Corp. stock rises Tuesday, still underperforms market
Shares of CVS Health Corp. CVS inched 0.10% higher to $51.57 Tuesday, on what proved to be an all-around positive trading ...
Why CVS Health (CVS) Led the Monday Upsurge?
We recently published a list of 10 Firms Dominate Monday Upsurge. In this article, we are going to take a look at where CVS ...
Hosted on MSN14h
What You Need To Know Ahead of CVS Health's Earnings Release
With a market cap of $64.8 billion, CVS Health Corporation (CVS) is a leading pharmacy innovation company providing a wide ...
FTC Says CVS, Cigna and UnitedHealth Abuse Middleman Role (3)
Units of CVS Health Corp., Cigna Group and UnitedHealth Group Inc. charged significantly more than the national average ...
After Falling More Than 40% in 2024, Can CVS Health Stock Turn Things Around This Year?
CVS Health (NYSE: CVS) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...
CVS Health stock price rises after Walgreens earnings: is it a buy?
The CVS Health stock price rebounded to $48 on Monday, up 10% from its lowest in December. This rebound continued after the ...
Do Dr. Oz's Health Care Stocks Create a Conflict of Interest?
If Oz is confirmed by the U.S. Senate, he'll immediately lead an agency that provides health care for 160 million Americans ...
Wells Fargo Reaffirms Their Buy Rating on CVS Health (CVS)
Wells Fargo analyst Stephen Baxter maintained a Buy rating on CVS Health (CVS – Research Report) on January 10 and set a price target of ...
Hosted on MSN14h
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
CVS Health (CVS) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...